Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 14:21
  • Read more about Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study

Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:56
  • Read more about Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis

The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:51
  • Read more about The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses

Causal relationship between blood metabolites and risk of five infections: a Mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:22
  • Read more about Causal relationship between blood metabolites and risk of five infections: a Mendelian randomization study

Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:19
  • Read more about Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study

Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:15
  • Read more about Multivariate Mendelian randomization provides no evidence for causal associations among both psoriasis and psoriatic arthritis, and skin cancer

Genome-Wide Association and Two-Sample Mendelian Randomization Analyses of Plasma Ghrelin and Gastrointestinal Cancer Risk

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:12
  • Read more about Genome-Wide Association and Two-Sample Mendelian Randomization Analyses of Plasma Ghrelin and Gastrointestinal Cancer Risk

Association between age at first birth and postpartum depression: A two-sample mendelian randomization analysis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 13:10
  • Read more about Association between age at first birth and postpartum depression: A two-sample mendelian randomization analysis

Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 12:36
  • Read more about Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis

Mendelian randomization analysis reveals fresh fruit intake as a protective factor for urolithiasis

Submitted by Viola Mäkelä on Thu, 10/12/2023 - 12:31
  • Read more about Mendelian randomization analysis reveals fresh fruit intake as a protective factor for urolithiasis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 337
  • Page 338
  • Page 339
  • Page 340
  • Current page 341
  • Page 342
  • Page 343
  • Page 344
  • Page 345
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement